title: Glomerular deposition of complex-forming glycoprotein heterogenous in charge (protein HC) in IgA nephropathy.
abstract: IgA immune complexes and polymeric IgA are presumed to play important roles in the development and progression of IgA nephropathy. Complex-forming glycoprotein heterogenous in charge (protein HC), being inhibitors of neutrophilic chemotaxis, has been reported as binding to IgA. As a working hypothesis it was assumed that complexes of protein HC and IgA are present in glomeruli from IgA nephropathy patient in stable state. In this study, we examined the glomerular deposition of protein HC in 40 patients with IgA nephropathy and in 10 patients with non-IgA nephropathy. We used highly specific antibody against protein HC, that does not cross-react with alpha-1-microglobulin. An immunofluorescent study revealed that 10 out of the 40 patients (25%) showed an intensity of 1+, 16 (40%) showed weak positive (+/-), and the other 14 (35%) were negative. There was no deposition of protein HC in non-IgA nephropathy patients. Histopathological analysis demonstrated a significant correlation between the intensity of glomerular-deposited protein HC and pathological activity (p less than 0.005); the latter was defined as having either crescents in more than 15% of the remaining glomeruli (excluding global sclerotic glomeruli), or segmental necrosis or sclerosis in more than 30% of the remaining glomeruli. A significant correlation was observed between pathological activity and the intensity of deposited IgG, IgA and IgM (p = 0.01), and lambda chain (p less than 0.005). Considering anti-inflammatory activity of protein HC, these results suggest that protein HC cannot protect sufficiently acute inflammation or tissue damages due to co-deposited IgG and IgM and/or other factors.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Third Department of Internal Medicine, Akita University School of Medicine, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Imai
authors.forename: H
authors.initials: H
authors.lastname: Wakui
authors.forename: T
authors.initials: T
authors.lastname: Ishino
authors.forename: A
authors.initials: A
authors.lastname: Komatsuda
authors.forename: Y
authors.initials: Y
authors.lastname: Nakamoto
authors.forename: A B
authors.initials: AB
authors.lastname: Miura
authors.forename: R
authors.initials: R
authors.lastname: Kobayashi
mesh_terms: D000293:Adolescent; D000328:Adult; D000510:Alpha-Globulins / Q000378:metabolism*; D015153:Blotting, Western; D002648:Child; D005260:Female; D005455:Fluorescent Antibody Technique; D005922:Glomerulonephritis, IGA / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D007070:Immunoglobulin A / Q000378:metabolism*; D007146:Immunoglobulin lambda-Chains / Q000378:metabolism; D007678:Kidney Glomerulus / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000378:metabolism*
chemical_list: D000510:Alpha-Globulins; D007070:Immunoglobulin A; D007146:Immunoglobulin lambda-Chains; D011480:Protease Inhibitors; C016001:alpha-1-microglobulin; C034639:polymeric IgA